Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT02842203
Use of ctDNA for Monitoring of Stage III Colorectal Cancer
Sponsor: University of Pittsburgh
View on ClinicalTrials.gov
Summary
This observational study will evaluate circulating tumor DNA (ctDNA) as a prognostic marker and as a monitor of disease recurrence in stage III colorectal cancer (CRC).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
137
Start Date
2016-09
Completion Date
2026-09
Last Updated
2025-11-06
Healthy Volunteers
No
Conditions
Locations (1)
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States